Charles Theuer - Nov 5, 2021 Form 4 Insider Report for Tracon Pharmaceuticals, Inc. (TCON)

Role
President and CEO, Director
Signature
/s/ Scott B. Brown, Attorney-in-Fact
Stock symbol
TCON
Transactions as of
Nov 5, 2021
Transactions value $
$13,655
Form type
4
Date filed
11/9/2021, 06:00 AM
Previous filing
Aug 18, 2021
Next filing
Nov 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCON Common Stock Purchase $3.41K +1K +0.47% $3.41 212K Nov 5, 2021 Direct F1
transaction TCON Common Stock Purchase $10.2K +3K +1.41% $3.42 215K Nov 5, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,405 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on October 20, 2021.